COMMUNIQUÉS West-GlobeNewswire

-
VALNEVA : Déclaration d'actions et de droits de vote octobre 2017
06/11/2017 - 18:00 -
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 31 octobre 2017
06/11/2017 - 18:00 -
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2017
06/11/2017 - 18:00 -
Le MABp1 de XBiotech fera l'objet d'une présentation orale lors des séances scientifiques de l'American Heart Association
06/11/2017 - 17:28 -
Ossur Hf : Transactions in relation to share buyback program
06/11/2017 - 17:00 -
Acarix AB to seek new CEO
06/11/2017 - 14:40 -
Adaptimmune marks Official Opening of U.K. Headquarters
06/11/2017 - 14:15 -
Novo Nordisk A/S - Share repurchase programme
06/11/2017 - 13:31 -
Minerva Neurosciences Reports Third Quarter 2017 Financial Results and Business Updates
06/11/2017 - 13:30 -
Summit Therapeutics Announces Revenue Sharing Agreement with Wellcome Trust
06/11/2017 - 13:00 -
iTeos Therapeutics to Present New Data at Upcoming 2017 SITC Annual Meeting
06/11/2017 - 13:00 -
Amer Sports Corporation: Managers' transactions
06/11/2017 - 13:00 -
PCI Biotech to present at BIO-Europe 2017
06/11/2017 - 10:32 -
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
06/11/2017 - 09:00 -
Orphazyme publishes offering circular and the indicative offer price range for its IPO
06/11/2017 - 08:37 -
Silmäasema Oyj: Silmäasema opens new eye clinic in the centre of Oulu
06/11/2017 - 08:00 -
Novartis seeks leadership with Cosentyx® showing no radiographic progression in ankylosing spondylitis at 4 years
06/11/2017 - 07:15 -
Novartis reaches another regulatory milestone for CTL019 (tisagenlecleucel) with submission of its MAA* to EMA for children, young adults with r/r B-cell ALL and adult patients with r/r DLBCL
06/11/2017 - 07:10 -
Medtronic Receives CE Mark for the World's Smallest Fully Implantable Spinal Cord Stimulator and Announces European Launch of the Intellis Platform
06/11/2017 - 07:00
Pages